Famar appoints Bruno Biscaro as President North America for the Group

Paris, March 21, 2018: In order to build the company’s business and grow its presence in North America, Ian Muir, CEO of Famar has appointed Bruno Biscaro as President, North America for the Famar Group. In this role, Bruno Biscaro will lead all Famar’s business activities and operations within the region.

As part of its strategy to better support existing and new customers within North America, Famar acquired the site of Pointe Claire, Montreal, in 2017. This investment was the company’s first step to solidify its presence within the region.

With the announcement of Bruno Biscaro, Famar strengthens its executive team with the objective of maximizing the development of the activities within the North American market.

Bruno brings over 30 years of leadership experience in building strong teams, establishing enduring customer relationships and creating superior performing businesses. He was most recently the President of Accucaps, an industry leading Contract Development and Manufacturing Organisation (CDMO).

Prior to that, Bruno Biscaro was the Regional Director of GlaxoSmithKline (GSK) as part of the North American Executive Team for Global Manufacturing and Supply.

He received a Bachelor’s Degree in Industrial Engineering from Ryerson University (Toronto, Canada) and a Master’s Degree from the University of Cambridge (Cambridge, United Kingdom).

About Pointe Claire facility

Acquired on April 1st of 2017, the Pointe-Claire (Montreal, Canada) Facility is the 12th and most recent site integrated in the Famar sites’ network. Previously belonging to Bayer and before that, to Merck and Schering-Plough, the site has a long-standing high-quality reputation within the Big Pharma’s. With its state-of-the-art technologies as a non-sterile Center of Excellence in Liquids, Semi-Solids and Nasal Sprays, the Site is the first in the Famar network to have the FDA license and exports currently more than 60% of its production to the US.

About Famar

Famar is a leading provider of Contract Manufacturing and Development Services to the Pharmaceutical and Health & Beauty industry. From development to production and distribution, Famar’ services enable the Health and Personal Care industry to deliver innovative and accessible solutions for the improvement of patients & consumers’ lives. We supply a wide range of more than 1800 products to a broad customer base in 125 international markets. Dotted with 12 production sites, out of which 11 are located in Europe (four in France, four in Greece, and single sites in Italy, Spain and the Netherlands) and one in North America, Famar has one of the largest European footprint’s in the sector.

Media contacts

Olivier Blain

Adding Value Conseils


+33 6 72 28 29 20

Catherine Kuttner



+33 6 08 70 39 12

In our website we use cookies enabling page navigation and access to specific website areas. Those cookies are necessary for the proper functioning of the website. We use as well statistic cookies that collect and report anonymous information, helping us to understand how visitors interact with our website. By clicking on the “I accept” button you agree on our use of cookies. If you require further information or don’t intend to accept our cookies, you can visit the “Term of use” page.